Moderna CEO Stéphane Bancel argued that the drug industry's efforts to prepare for a future pandemic are part of efforts to ...

The Alliance for Pharmacy Compounding told the FDA last week that Novo Nordisk's weight loss medicine semaglutide is not too ...

The Biden Administration said Wednesday that it has secured agreements with Vertex Pharmaceuticals and bluebird bio for their ...

Novo Nordisk is buying a vaccine manufacturing factory from Novavax for $200 million to expand production of its current and ...

Relmada Therapeutics said Wednesday morning that a Phase 3 study testing its major depression drug, REL-1017, is likely to ...

GeneDx was teetering. The genetic testing company had laid off 33% of its staff, shares were down 90% from a year prior, and ...

UnitedHealthcare CEO Brian Thompson was shot and killed in Midtown Manhattan on Wednesday morning, according to media reports ...

Atea Pharmaceuticals reported positive Phase 2 trial results for its hepatitis C combination therapy of bemnifosbuvir and ...

GSK partners with Duality Biologics in a $30 million upfront deal, potentially worth $975 million, for access to a ...

The market for first-generation weight loss treatments has been dominated by two major players, Eli Lilly and Novo Nordisk.

Versant is out with its third obesity biotech of the year, leading an €80 million Series A for Antag Therapeutics, a Danish ...

Eli Lilly has removed the commonly used clinical measure of body mass index from the FDA label for its weight loss drug ...